Sort
30,917 grants matching “tumor microenvironment”
Mechanisms of Immune Evasion by Ocular Tumors
$374,963Kyle C McKenna · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · EY
Overcoming Barriers of Virotherapy by Next-Generation oHSV Expressing E-Cadherin
$374,912Jianhua Yu · Beckman Research Institute/City Of Hope · R01 · FY2023 · NS
Overcoming Barriers of Virotherapy by Next-Generation oHSV Expressing E-Cadherin
$374,912Jianhua Yu · Beckman Research Institute/City Of Hope · R01 · FY2022 · NS
Crosstalk between glioma cells & immune cells in the tumor microenvironment: Ther
$374,910Maria G Castro · University Of Michigan At Ann Arbor · R01 · FY2015 · NS
Antigen-independent prediction and biomarker identification of cancer-specific T cells
$374,864Bo Li · Ut Southwestern Medical Center · R01 · FY2021 · CA
In Vivo Genetic Analysis of Compartmentalized Cell Elimination
$374,863Piya Ghose · University Of Texas Arlington · R35 · FY2023 · GM
Migration Networks
$374,840Frank B Gertler · Massachusetts Institute Of Technology · U54 · FY2012 · CA
Project-2:Defining the role of compartmentalized neuro-lymphatic networks on CRC and metastatic progression
$374,791Daniel S Mucida · Rockefeller University · U54 · FY2023 · CA
In Situ characterization and manipulation of tumor immune cell metabolomics using implantable microdevices
$374,782Oliver Jonas · Brigham And Women'S Hospital · R01 · FY2019 · CA
The impact of reduction of cellular senescence on age-related epigenetic heterogeneity
$374,770Sheng Li · University Of Southern California · U01 · FY2024 · CA
Lifestyle associated reactive metabolites and their negative impact on breast cancer risk
$374,770Victoria Jane Findlay · Virginia Commonwealth University · R01 · FY2024 · CA
Exploiting Pyrimidine Nucleotide Synthesis Dependence for IDH Mutant Glioma Therapy
$374,769Samuel Kent McBrayer · Ut Southwestern Medical Center · R01 · FY2021 · CA
Project 4: Chimeric Antigen Receptor T Cell Therapy for the Treatment of Acute Myeloid Leukemia
$374,759Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
Project 3: Modulation of the head and neck tumor immune microenvironment by targeting the TAM family of receptors
$374,756Deric L Wheeler · University Of Wisconsin-Madison · P50 · FY2022 · CA
Regulation of Signaling Receptor Activity by LRP-1
$374,740Steven L. Gonias · University Of California, San Diego · R01 · FY2014 · HL
Targeted inhibition in stromal TGFβ activity in pancreatic cancer
$374,691Rolf A Brekken · Ut Southwestern Medical Center · R01 · FY2020 · CA
Role of the collagen receptor LAIR-1 in glioma progression and the tumor immune microenvironment
$374,685Pedro R Lowenstein · University Of Michigan At Ann Arbor · R01 · FY2024 · NS
Targeting Oncogenic KRAS with Brush-Architectured Poly(ethylene glycol)-DNA Conjugates
$374,660Ke Zhang · Northeastern University · R01 · FY2021 · CA
Hypoxia, DNA repair, and gene silencing
$374,625Peter M Glazer · Yale University · R01 · FY2019 · ES
Hypoxia, DNA repair, and gene silencing
$374,625Peter M Glazer · Yale University · R01 · FY2017 · ES
Hypoxia, DNA repair, and gene silencing
$374,625Peter M Glazer · Yale University · R01 · FY2018 · ES
Hypoxia, DNA repair, and gene silencing
$374,625Peter M Glazer · Yale University · R01 · FY2015 · ES
Hypoxia, DNA repair, and gene silencing
$374,625Peter M Glazer · Yale University · R01 · FY2016 · ES
CD38 Pretargeted Radioimmunotherapy for Myeloma
$374,608Oliver W. Press · Fred Hutchinson Cancer Research Center · R01 · FY2011 · CA
ER STRESS AS EARLY SENSOR OF NUTRIENT DEPRIVATION
$374,594J. Alan Diehl · University Of Pennsylvania · P01 · FY2008 · CA